 Date: 2010-10-13 11:06:53Medicine Intellectual property law Monopoly Pharmaceutical sciences Sulfoxides Omeprazole Supplementary protection certificate Test data exclusivity Astra AB Proton pump inhibitors AstraZeneca Pharmacology | |  Antitrust AstraZeneca: the first abuse case in the pharmaceutical sector Niklas FAGERLUND and Søren Bo RASMUSSEN, Directorate-General Competition, unit B-2 1. Introduction
Add to Reading ListSource URL: ec.europa.euDownload Document from Source Website File Size: 90,70 KBShare Document on Facebook
|
